R. Mark Adams, Chief Operating Officer at Adaptive Biotechnologies Corp (ADPT), sold 1,021 shares at $23.32 ($24K) on 2022-01-07, disclosed to the SEC on 2022-01-10.
Open-market sale of $24k ADPT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2023-01-11 | $27K | — | Filing → |
| ADPT | SELL | 2022-10-11 | $23K | — | Filing → |
| ADPT | SELL | 2022-07-08 | $32K | — | Filing → |